NVST vs. BSX

Last updated Apr 1, 2026

Compare and contrast key facts about Envista Holdings Corporation (NVST) and Boston Scientific Corporation (BSX).

Performance

NVST vs. BSX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Envista Holdings Corporation (NVST) and Boston Scientific Corporation (BSX). The values are adjusted to include any dividend payments, if applicable.

NVST vs. BSX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
NVST Envista Holdings Corporation	16.86%	12.55%	-19.83%	-28.54%	-25.28%	33.59%	13.80%	6.05%
BSX Boston Scientific Corporation	-34.19%	6.75%	54.51%	24.94%	8.92%	18.16%	-20.50%	5.41%

Fundamentals

Market Cap NVST : $4.21B BSX : $93.86B
EPS NVST : $0.28 BSX : $1.93
PE Ratio NVST : 91.08 BSX : 32.46
PEG Ratio NVST : 1.10 BSX : 0.73
PS Ratio NVST : 1.57 BSX : 4.67
PB Ratio NVST : 1.36 BSX : 3.87
Total Revenue (TTM) NVST : $2.72B BSX : $20.08B
Gross Profit (TTM) NVST : $1.49B BSX : $13.85B
EBITDA (TTM) NVST : $327.80M BSX : $4.91B

Returns By Period

In the year-to-date period, NVST achieves a 16.86% return, which is significantly higher than BSX's -34.19% return.

NVST

• 1D: 4.58%
• 1M: -13.15%
• YTD: 16.86%
• 6M: 24.55%
• 1Y: 46.99%
• 3Y*: -14.70%
• 5Y*: -9.08%
• 10Y*: —

BSX

• 1D: -0.29%
• 1M: -18.35%
• YTD: -34.19%
• 6M: -35.73%
• 1Y: -37.80%
• 3Y*: 7.84%
• 5Y*: 10.22%
• 10Y*: 12.73%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

NVST vs. BSX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NVST

NVST Risk / Return Rank: 78
NVST Sharpe Ratio Rank: 77
NVST Sortino Ratio Rank: 77
NVST Omega Ratio Rank: 73
NVST Calmar Ratio Rank: 82
NVST Martin Ratio Rank: 83

BSX

BSX Risk / Return Rank: 4
BSX Sharpe Ratio Rank: 2
BSX Sortino Ratio Rank: 5
BSX Omega Ratio Rank: 3
BSX Calmar Ratio Rank: 9
BSX Martin Ratio Rank: 0

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NVST vs. BSX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Envista Holdings Corporation (NVST) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NVST	BSX	Difference
Sharpe ratio Return per unit of total volatility	1.11	-1.21	+2.32
Sortino ratio Return per unit of downside risk	1.92	-1.59	+3.50
Omega ratio Gain probability vs. loss probability	1.23	0.75	+0.48
Calmar ratio Return relative to maximum drawdown	2.50	-0.88	+3.37
Martin ratio Return relative to average drawdown	7.08	-2.47	+9.55
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NVST vs. BSX - Sharpe Ratio Comparison

The current NVST Sharpe Ratio is 1.11, which is higher than the BSX Sharpe Ratio of -1.21. The chart below compares the historical Sharpe Ratios of NVST and BSX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	NVST	BSX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.11	-1.21	+2.32
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.25	0.42	-0.68
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.48	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.04	0.22	-0.26

Correlation

The correlation between NVST and BSX is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

NVST vs. BSX - Dividend Comparison

Neither NVST nor BSX has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

NVST vs. BSX - Drawdown Comparison

The maximum NVST drawdown since its inception was -71.00%, smaller than the maximum BSX drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for NVST and BSX.

Drawdown Indicators

	NVST	BSX	Difference
Max Drawdown Largest peak-to-trough decline	-71.00%	-89.15%	+18.15%
Max Drawdown (1Y) Largest decline over 1 year	-19.83%	-41.97%	+22.14%
Max Drawdown (5Y) Largest decline over 5 years	-71.00%	-41.97%	-29.03%
Max Drawdown (10Y) Largest decline over 10 years	—	-43.49%	—
Current Drawdown Current decline from peak	-50.16%	-41.97%	-8.19%
Average Drawdown Average peak-to-trough decline	-34.58%	-38.71%	+4.13%
Ulcer Index Depth and duration of drawdowns from previous peaks	6.99%	14.94%	-7.95%

Volatility

NVST vs. BSX - Volatility Comparison

Envista Holdings Corporation (NVST) has a higher volatility of 12.68% compared to Boston Scientific Corporation (BSX) at 11.48%. This indicates that NVST's price experiences larger fluctuations and is considered to be riskier than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NVST	BSX	Difference
Volatility (1M) Calculated over the trailing 1-month period	12.68%	11.48%	+1.20%
Volatility (6M) Calculated over the trailing 6-month period	28.72%	27.07%	+1.65%
Volatility (1Y) Calculated over the trailing 1-year period	42.71%	31.31%	+11.40%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	35.86%	24.21%	+11.65%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	40.04%	26.76%	+13.28%

Financials

NVST vs. BSX - Profitability Comparison

The chart below illustrates the profitability comparison between Envista Holdings Corporation and Boston Scientific Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

NVST - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Envista Holdings Corporation reported a gross profit of 410.60M and revenue of 750.60M. Therefore, the gross margin over that period was 54.7%.

BSX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Boston Scientific Corporation reported a gross profit of 3.94B and revenue of 5.29B. Therefore, the gross margin over that period was 74.5%.

NVST - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Envista Holdings Corporation reported an operating income of 73.30M and revenue of 750.60M, resulting in an operating margin of 9.8%.

BSX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Boston Scientific Corporation reported an operating income of 1.21B and revenue of 5.29B, resulting in an operating margin of 22.8%.

NVST - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Envista Holdings Corporation reported a net income of 32.90M and revenue of 750.60M, resulting in a net margin of 4.4%.

BSX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Boston Scientific Corporation reported a net income of 668.00M and revenue of 5.29B, resulting in a net margin of 12.6%.